A New Frontier Of Genomics And Aging

Accessible solutions for proactive aging prevention and performance enhancement from the genetic roots with agentic AI

Precision Genome Editing

Novel breakthrough in genome editing technology, designed to achieve highest precision and efficiency

Agentic AI Platform

An LLM-powered, multi-agent platform specialized in genetic interventions automates end-to-end scientific discovery, enabling low-cost, rapid iterations with high confidence and delivering advantageous genetic variants to the general population.

World's First Genome Editing Platform That Can Be Fine Tuned

Proprietary genome editing technology that enables fine tuning of genome editing to optimize precision, efficacy and safety

Safeguard Technology

A revolutionary technology that enhances the safety and precision of genome editing, enabling the development of transformative therapies

7x Editing Efficiency

Continuous fine-tuning is important for determining the optimal editing activity and efficiency

100x Safety

Prioritizes safety by significantly reducing adverse effects such as p53 activation, cytotoxicity and DNA damage, ensuring that gene editing is performed accurately and securely.

3000x Precision

Unparalleled precision, lowering off-targets, enabling genome editing with increased accuracy and control

Meet Our Founders

George Church, PhD

Co-Founder

Professor of Genetics at Harvard Medical School

Professor of Health Sciences and Technology, Harvard and MIT

George Church, Ph.D., is a professor at Harvard and MIT, leading the Church Lab at Harvard Medical School and serving as a Core Faculty member of the Wyss Institute, where he directs the Synthetic Biology Platform. A renowned leader in genomics and aging, Church is a key figure in the development and advancement of CRISPR gene-editing technology. He has co-founded and been involved in companies focused on genome editing and gene therapies.

While Church’s work spans many areas of genomics and aging, his groundbreaking contributions include the development of the first direct genomic sequencing method and barcode-multiplexing tags in collaboration with Wally Gilbert in 1984, which laid the foundation for innovations in sequencing technologies and genome editing. He is also involved in AI efforts aimed at advancing superintelligence, exploring broad scientific and technological applications.